Thailand Hereditary Angioedema Market (2025-2031) | Forecast, Companies, Analysis, Growth, Trends, Competitive Landscape, Segmentation, Share, Industry, Outlook, Value, Size & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Thailand Country Macro Economic Indicators

3.2 Thailand Hereditary Angioedema Market Revenues & Volume, 2021 & 2031F

3.3 Thailand Hereditary Angioedema Market - Industry Life Cycle

3.4 Thailand Hereditary Angioedema Market - Porter's Five Forces

3.5 Thailand Hereditary Angioedema Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 Thailand Hereditary Angioedema Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 Thailand Hereditary Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about hereditary angioedema (HAE) among healthcare professionals and patients in Thailand

4.2.2 Growing investments in research and development for innovative HAE treatments

4.2.3 Rising prevalence of HAE cases in Thailand, leading to higher demand for effective therapies

4.3 Market Restraints

4.3.1 Limited access to advanced HAE treatments due to high costs

4.3.2 Lack of specialized healthcare facilities for the diagnosis and management of HAE in Thailand

4.3.3 Regulatory challenges and delays in the approval of new HAE therapies in the market

6.1 Thailand Hereditary Angioedema Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 Thailand Hereditary Angioedema Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 Thailand Hereditary Angioedema Market Revenues & Volume, By C1 Esterase Inhibitor, 2021- 2031F

6.1.4 Thailand Hereditary Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F

6.1.5 Thailand Hereditary Angioedema Market Revenues & Volume, By Kallikrein Inhibitor, 2021- 2031F

6.1.6 Thailand Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F

6.2 Thailand Hereditary Angioedema Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 Thailand Hereditary Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F

6.2.3 Thailand Hereditary Angioedema Market Revenues & Volume, By Subcutaneous Injection, 2021- 2031F

6.2.4 Thailand Hereditary Angioedema Market Revenues & Volume, By Oral, 2021- 2031F

6.3 Thailand Hereditary Angioedema Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 Thailand Hereditary Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.3.3 Thailand Hereditary Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.3.4 Thailand Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F

7.1 Thailand Hereditary Angioedema Market Export to Major Countries

7.2 Thailand Hereditary Angioedema Market Imports from Major Countries

8.1 Number of HAE patients diagnosed and under treatment in Thailand

8.2 Adoption rate of new HAE therapies by healthcare providers in the country

8.3 Rate of successful management of acute HAE attacks using available treatments

9.1 Thailand Hereditary Angioedema Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 Thailand Hereditary Angioedema Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 Thailand Hereditary Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Thailand Hereditary Angioedema Market Revenue Share, By Companies, 2024

10.2 Thailand Hereditary Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters